1. Home
  2. IMAB vs KNOP Comparison

IMAB vs KNOP Comparison

Compare IMAB & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • KNOP
  • Stock Information
  • Founded
  • IMAB 2014
  • KNOP 2013
  • Country
  • IMAB United States
  • KNOP United Kingdom
  • Employees
  • IMAB N/A
  • KNOP N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • KNOP Marine Transportation
  • Sector
  • IMAB Health Care
  • KNOP Consumer Discretionary
  • Exchange
  • IMAB Nasdaq
  • KNOP Nasdaq
  • Market Cap
  • IMAB 200.9M
  • KNOP 239.7M
  • IPO Year
  • IMAB 2020
  • KNOP 2013
  • Fundamental
  • Price
  • IMAB $4.87
  • KNOP $7.22
  • Analyst Decision
  • IMAB Strong Buy
  • KNOP
  • Analyst Count
  • IMAB 3
  • KNOP 0
  • Target Price
  • IMAB $6.33
  • KNOP N/A
  • AVG Volume (30 Days)
  • IMAB 4.2M
  • KNOP 41.9K
  • Earning Date
  • IMAB 05-15-2025
  • KNOP 09-02-2025
  • Dividend Yield
  • IMAB N/A
  • KNOP 1.43%
  • EPS Growth
  • IMAB N/A
  • KNOP N/A
  • EPS
  • IMAB N/A
  • KNOP 0.19
  • Revenue
  • IMAB N/A
  • KNOP $320,026,000.00
  • Revenue This Year
  • IMAB N/A
  • KNOP $9.01
  • Revenue Next Year
  • IMAB N/A
  • KNOP $0.42
  • P/E Ratio
  • IMAB N/A
  • KNOP $38.45
  • Revenue Growth
  • IMAB N/A
  • KNOP 8.76
  • 52 Week Low
  • IMAB $0.60
  • KNOP $5.28
  • 52 Week High
  • IMAB $5.90
  • KNOP $7.72
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 75.47
  • KNOP 57.02
  • Support Level
  • IMAB $3.30
  • KNOP $6.90
  • Resistance Level
  • IMAB $3.94
  • KNOP $7.52
  • Average True Range (ATR)
  • IMAB 0.58
  • KNOP 0.19
  • MACD
  • IMAB 0.23
  • KNOP 0.01
  • Stochastic Oscillator
  • IMAB 76.12
  • KNOP 60.53

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests

KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.

Share on Social Networks: